PLUR - pluri-biotech.com Qarzning balans kapitallashuviga nisbati

Pluri (PLUR) grafik logotipi

Placentali terapiya uchun premium narxlar aksiyalar o'sishini rag'batlantirmoqda, buni kitob kapitalizatsiyasiga asoslangan moliyaviy leveraj koeffitsiyenti isbotlaydi. Biroq, Yaqin Sharqdagi mojarolar barqarorlikka putur yetkazmoqda va ekologik profil bio-chiqindilarni utilizatsiya qilish bilan cheklangan. 0.00 ning joriy qiymati qarz yuklamasi ko'rsatkichi bo'lib, u Pluri Inc. (PLUR) moliyaviy mustaqilligi va biznes kengayish sur'atlari o'rtasidagi muvozanatni namoyish etadi.

PLUR (Pluri) Qarzning balans qiymatiga nisbati tarixi 28.04.2023dan 27.10.2026gacha
Pluri asosiy tovari

Ushbu koeffitsiyent moliyaviy majburiyatlarning kapitalga nisbatini belgilab, kompaniyaning haqiqiy qarz yuklamasini o'lchaydi. Ushbu qiymatning oshishi moliyaviy tuzilmaning haddan tashqari qiziganligidan va defolt xatarlarining ortganligidan dalolat beradi. Qarz va balans kapitali o'rtasidagi joriy bog'liqlikni tahlil qilish orqali investor biznesni kengaytirishning barqarorligini baholaydi. Pluri Inc. (PLUR) uchun bu Isroilda energiyaga bog'liq bioreaktorlarni saqlashda juda muhimdir. Ushbu metrikaning monitoringi kompaniyaning qimmatga tushadigan hujayra terapiyasi infratuzilmasini qo'llab-quvvatlash qobiliyatini tasdiqlaydi.

Pluri Inc. (PLUR) raqobatchilari

Balans kapitallashuviga qarzlar ASND (Ascendis Pharma A/S)|madrigalpharma.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Corcept Therapeutics Incorporated (CORT)|RYTM: Qarzning sof aktivlarga nisbati|AKRO (Akero Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Metsera Therapeutics (MTSR) - Qarzning balans qiymatiga nisbati|MLTX (MoonLake Immunotherapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar crinetics.com (CRNX)|NewAmsterdam Pharma Company N.V. (NAMS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati SLNO (Soleno Therapeutics Inc)|Amicus Pharma - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati 89bio Pharma ETNB|AGIO (Agios Pharmaceuticals) - Balans kapitallashuviga qarzlar|structuretx.com (GPCR) - Balans qiymatiga qarzlar|MDXG - Qarzning balans qiymatiga nisbati|Rezolute Inc (RZLT) - Qarzning balans kapitaliga nisbati|LXRX (Lexicon Pharma) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar MBX Corp|Balans kapitallashuviga qarzlar Altimmune, Inc. (ALT)|Qarzning balans kapitallashuviga nisbati AARD (aardvarktherapeutics.com)|SGMT: Qarzning balans kapitallashuviga nisbati|BioAge Labs - Balans qiymatiga qarzlar|BMEA - Qarzning balans kapitallashuviga nisbati|QNCX - Qarzning balans kapitallashuviga nisbati|Fractyl Health, Inc. - Balans kapitallashuviga qarzlar|VTVT (vTv Therapeutics) - Sof aktivlarga qarzlar|ATPC: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar SYBX|Qarzning balans kapitallashuviga nisbati LPCN (Lipocine Corp)|Qarzning balans qiymatiga nisbati MTNB (matinasbiopharma.com)|Spruce Biosciences, Inc. (SPRB) - Qarzning balans kapitallashuviga nisbati|galecto.com - Qarzlarning balans kapitallashuviga nisbati|CTCX - Qarzning balans kapitallashuviga nisbati|Lumos Pharma Inc (LUMO) - Qarzning balans kapitallashuviga nisbati|ONVO: Qarzning balans qiymatiga nisbati|RDUS (Radius Pharmaceuticals) - Balans kapitallashuviga qarzlar